Thus, Wong et al. reported in 2020 that in the peripheral blood of MCC patients, circulating CD8+ T cells reactive to MCPyV T antigen (T-Ag) were subjected to anti-PD-1 immunotherapy [187]. This evidence concerns the gene CD8A and Merkel cell skin cancer.